Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03615001 · ClinicalTrials.gov registry record · NA
T-DOC® NXT Clinical Investigation
A NA study, sponsored by Laborie Medical Technologies.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03615001 is a NA study that has completed, run by Laborie Medical Technologies. The registered enrollment target is 20 participants.
The verdict
NCT03615001, a NA study, has completed, sponsored by Laborie Medical Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Assessing the Performance, Safety and Usability of our Next Generation T-DOC® NXT Catheter for Performing Urodynamic Studies
Interventions
- DEVICE TDOC NXT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2018-10-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03615001
The ClinicalTrials.gov registry entry for NCT03615001 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laborie Medical Technologies, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TDOC NXT is the first listed.
NCT03615001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03615001 about?
NCT03615001 is a clinical study titled "T-DOC® NXT Clinical Investigation". Assessing the Performance, Safety and Usability of our Next Generation T-DOC® NXT Catheter for Performing Urodynamic Studies
What is the current status of trial NCT03615001?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-07-18. Estimated completion is 2018-10-04.
What interventions are being tested in trial NCT03615001?
The interventions under investigation include: TDOC NXT (DEVICE).
Who is sponsoring clinical trial NCT03615001?
This trial is sponsored by Laborie Medical Technologies, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.